RPG Life Sciences Limited (NSE:RPGLIFE)
India · Delayed Price · Currency is INR 2,172.40
-52.30 (-2.35%)
Jun 1, 2026, 3:29 PM IST
RPG Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,152 | 1,832 | 876.6 | 676.4 | 514.8 |
Depreciation & Amortization | 214.8 | 211.5 | 164.5 | 146.9 | 148.5 |
Other Amortization | - | 2.8 | 6.2 | 8.1 | 8.1 |
Loss (Gain) From Sale of Assets | -0.1 | -12 | -0.1 | 7.8 | - |
Asset Writedown & Restructuring Costs | 91.6 | - | - | - | - |
Loss (Gain) From Sale of Investments | -64.4 | -69.6 | -57.7 | -14.4 | -8.9 |
Provision & Write-off of Bad Debts | 7.5 | -16.2 | 27 | 5 | 0.9 |
Other Operating Activities | -404.4 | -909.8 | -2 | -32.1 | 15.2 |
Change in Accounts Receivable | -296.3 | -357.5 | -142.5 | -54 | 248.1 |
Change in Inventory | -308.6 | 61.9 | -59.5 | -120.6 | -246.6 |
Change in Accounts Payable | 176.1 | 95.4 | 63.3 | 192.6 | -19.1 |
Change in Other Net Operating Assets | -2.9 | -60.3 | 67.8 | 92.5 | -13.5 |
Operating Cash Flow | 565 | 778.6 | 943.6 | 908.2 | 647.5 |
Operating Cash Flow Growth | -27.43% | -17.49% | 3.90% | 40.26% | 11.12% |
Capital Expenditures | -653.6 | -360.3 | -692.3 | -327.3 | -239.5 |
Sale of Property, Plant & Equipment | - | 1,095 | 1.5 | 0.8 | - |
Investment in Securities | 484.5 | -287.9 | -269.6 | -569.9 | -119.7 |
Other Investing Activities | 1,028 | -864.5 | 168.9 | -161.7 | 12.6 |
Investing Cash Flow | 858.4 | -418 | -791.5 | -1,058 | -346.6 |
Long-Term Debt Issued | 200 | - | - | - | - |
Total Debt Issued | 200 | - | - | - | - |
Short-Term Debt Repaid | - | - | - | -2.7 | -3.1 |
Long-Term Debt Repaid | - | - | -0.1 | -6.6 | -7.7 |
Total Debt Repaid | - | - | -0.1 | -9.3 | -10.8 |
Net Debt Issued (Repaid) | 200 | - | -0.1 | -9.3 | -10.8 |
Common Dividends Paid | -396.9 | -264.6 | -198.5 | -158.8 | -119.1 |
Other Financing Activities | -8.9 | -6.2 | -4.5 | -3.1 | -5.2 |
Financing Cash Flow | -205.8 | -270.8 | -203.1 | -171.2 | -135.1 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.1 | - |
Net Cash Flow | 1,218 | 89.8 | -51 | -321.2 | 165.8 |
Free Cash Flow | -88.6 | 418.3 | 251.3 | 580.9 | 408 |
Free Cash Flow Growth | - | 66.45% | -56.74% | 42.38% | -18.01% |
Free Cash Flow Margin | -1.25% | 6.40% | 4.32% | 11.33% | 9.27% |
Free Cash Flow Per Share | -5.36 | 25.29 | 15.19 | 35.12 | 24.67 |
Cash Interest Paid | 8.9 | 6.2 | 4.5 | 3.1 | 5.2 |
Cash Income Tax Paid | 372.2 | 527.5 | 293.1 | 252.3 | 188.5 |
Levered Free Cash Flow | -152.3 | 325.59 | 222.04 | 487.99 | 350.38 |
Unlevered Free Cash Flow | -146.74 | 329.46 | 224.85 | 489.93 | 353.63 |
Change in Working Capital | -431.7 | -260.5 | -70.9 | 110.5 | -31.1 |